SunOpta Shareholders Approve Acquisition at $6.50 per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy STKL?
SunOpta announced that its shareholders approved the proposed acquisition of the Company by an affiliate of Refresco Holding for $6.50 per share in cash pursuant to the previously-announced plan of arrangement under the Canada Business Corporations Act at the Company's special meeting of shareholders held on April 16. The Arrangement was approved by 98.06% of the votes cast at the special meeting, and a non-binding, advisory executive compensation proposal was approved by 82.45% of the votes cast at the special meeting. The closing of the Arrangement is subject to remaining regulatory clearance or approval, approval by the Ontario Superior Court of Justice, and the satisfaction or waiver of other customary closing conditions. The hearing for the final order to approve the Arrangement before the Ontario Superior Court of Justice is scheduled to be held on April 22.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy STKL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on STKL
Wall Street analysts forecast STKL stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 6.490
Low
8.00
Averages
8.00
High
8.00
Current: 6.490
Low
8.00
Averages
8.00
High
8.00
About STKL
SunOpta Inc. operates as a partner, solutions provider and value-added manufacturer for various brands, and produces its own brands, including SOWN, Dream and West Life. The Company is focused on organic, non-genetically modified (non-GMO) and specialty foods. The Company's product categories include fruit-based snacks, plant-based beverages, plant-based ingredients, broth and stock, and liquid packaged and bulk tea concentrate. Its fruit-based snacks include fruit bars, bits, twists, strips, and pressed bars and strips. The Company's plant-based beverages include oat milk, soymilk, almond milk, coconut milk, hemp milk, and other nut, grain, seed & legume-based beverages. Its plant-based ingredients include oat base and soy base. It sells its products through various distribution channels, including foodservice operators, grocery retailers and club stores, branded food companies, and food manufacturers, located principally in the United States, as well as e-commerce channels.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cash-Rich Companies: Strong Flow but Investment Risks
- SunOpta's Declining Performance: SunOpta (NASDAQ:STKL) has seen a 1.6% annual decline in sales over the past three years, and despite a free cash flow margin of 4.8%, its revenue base of $792.4 million puts it at a disadvantage, indicating a lack of loyal customers for its products.
- ProFrac's Financial Strain: ProFrac (NASDAQ:ACDC) has a poor free cash flow margin of just 1%, with a gross margin of 32.8% that is below its competitors, limiting its ability to invest in exploration and production, while its EBITDA margin has decreased by 1.6 percentage points over the last five years.
- Boston Scientific's Growth Potential: Boston Scientific (NYSE:BSX) has achieved an average organic revenue growth rate of 16.6% over the past two years, with annual earnings per share growth of 26%, and a free cash flow margin that increased by 7 percentage points over five years, showcasing its strong profitability and investment potential.
- Rising Market Attention: While SunOpta and ProFrac face challenges, Boston Scientific's stock price of $64.08, with a P/E ratio of 18.7, indicates increasing attractiveness in the market, potentially making it a focal point for investors.
See More
SunOpta Shareholders Approve Acquisition by Refresco
- Acquisition Approval: SunOpta shareholders approved the acquisition by Refresco with 98.1% of votes at a special meeting, valuing the company at $1.1 billion with a deal price of $6.50 per share, marking a significant strategic shift.
- Pending Regulatory Clearance: Although the acquisition has shareholder backing, it still requires approval from the Ontario Superior Court and satisfaction of other customary closing conditions, indicating complexities and uncertainties in finalizing the deal.
- Suspension of Financial Guidance: In light of the pending transaction, SunOpta has suspended its quarterly earnings calls and will no longer provide quarterly or annual guidance, which may affect investor expectations regarding the company's future performance.
- CEO's Strategic Vision: CEO Brian Kocher emphasized that the partnership with Refresco will provide the necessary resources and scale to unlock SunOpta's full potential in the rapidly growing better-for-you food and beverage market, further solidifying its market position.
See More
SunOpta Cleared for Acquisition by Refresco
- Acquisition Approval: SunOpta Inc. (STKL) has received early termination approval under the Hart-Scott-Rodino Antitrust Improvements Act, facilitating the acquisition process and marking a key condition met for the deal.
- Transaction Details: Refresco is acquiring SunOpta for $6.50 per share in an all-cash transaction valued at $1.1 billion, expected to close this quarter, indicating Refresco's strong intent to acquire.
- Regulatory Requirements: Despite the early approval, the acquisition still requires remaining regulatory clearances, approval from SunOpta shareholders, and consent from the Ontario Superior Court, ensuring compliance and legality of the transaction.
- Market Impact: This acquisition is poised to not only expand Refresco's market share but also potentially provide SunOpta with new growth opportunities, further driving its expansion in the consumer goods sector.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating Peakstone Realty Trust (NYSE:PKST) for its sale to Brookfield Asset Management at $21.00 per share in cash, which may infringe on shareholder rights.
- Shareholder Rights Protection: Coterra Energy Inc. (NYSE:CTRA) is being sold to Devon Energy Corporation for 0.70 shares of Devon stock per Coterra share, prompting Halper Sadeh LLC to encourage shareholders to understand their legal rights and options.
- Transaction Terms Review: The deal between Udemy, Inc. (NASDAQ:UDMY) and Coursera, Inc. involves exchanging 0.800 shares of Coursera stock for each Udemy share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
- Legal Service Commitment: Halper Sadeh LLC offers legal services on a contingency fee basis, aiming to secure greater rights for affected shareholders and ensure their legal interests are protected in these transactions.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating companies such as Calavo Growers, Inc., European Wax Center, Inc., and SunOpta Inc. for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights.
- Transaction Details: Calavo Growers is being sold for $14.85 in cash and 0.9790 shares of Mission Produce per share, while European Wax Center's sale price is $5.80 per share in cash, and SunOpta's is $6.50 per share in cash, potentially limiting superior competing offers.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options, promising to handle matters on a contingent fee basis, aiming to secure increased consideration and additional disclosures for affected shareholders.
- Legal Service Commitment: The firm represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors in the past, demonstrating its expertise in protecting investor rights.
See More
Investigation Alerts for Multiple Company Mergers
- Rallybio Merger Investigation: Rallybio is set to be acquired by Candid Therapeutics, with pre-transaction shareholders expected to own approximately 3.65% of the combined entity, raising concerns about whether the board breached fiduciary duties by failing to ensure a fair process, potentially impacting shareholder rights.
- SunOpta Acquisition Details: SunOpta will be acquired by Refresco for $6.50 per share in cash, with investigations focusing on whether the board violated fiduciary duties by not securing fair value for shareholders in the transaction.
- Talkspace Transaction Review: Talkspace is being acquired by Universal Health Services for $5.25 per share in an all-cash deal worth $835 million, with investigations questioning whether the board failed to conduct a fair process, which could harm shareholder interests.
- Kennedy-Wilson Merger Investigation: Kennedy-Wilson will be acquired by a consortium, including its chairman, for $10.90 per share in cash, with investigations looking into whether the board breached fiduciary duties by not ensuring a fair transaction process, potentially affecting shareholder value.
See More
Cash-Rich Companies: Strong Flow but Investment Risks
- SunOpta's Declining Performance: SunOpta (NASDAQ:STKL) has seen a 1.6% annual decline in sales over the past three years, and despite a free cash flow margin of 4.8%, its revenue base of $792.4 million puts it at a disadvantage, indicating a lack of loyal customers for its products.
- ProFrac's Financial Strain: ProFrac (NASDAQ:ACDC) has a poor free cash flow margin of just 1%, with a gross margin of 32.8% that is below its competitors, limiting its ability to invest in exploration and production, while its EBITDA margin has decreased by 1.6 percentage points over the last five years.
- Boston Scientific's Growth Potential: Boston Scientific (NYSE:BSX) has achieved an average organic revenue growth rate of 16.6% over the past two years, with annual earnings per share growth of 26%, and a free cash flow margin that increased by 7 percentage points over five years, showcasing its strong profitability and investment potential.
- Rising Market Attention: While SunOpta and ProFrac face challenges, Boston Scientific's stock price of $64.08, with a P/E ratio of 18.7, indicates increasing attractiveness in the market, potentially making it a focal point for investors.
See More
SunOpta Shareholders Approve Acquisition by Refresco
- Acquisition Approval: SunOpta shareholders approved the acquisition by Refresco with 98.1% of votes at a special meeting, valuing the company at $1.1 billion with a deal price of $6.50 per share, marking a significant strategic shift.
- Pending Regulatory Clearance: Although the acquisition has shareholder backing, it still requires approval from the Ontario Superior Court and satisfaction of other customary closing conditions, indicating complexities and uncertainties in finalizing the deal.
- Suspension of Financial Guidance: In light of the pending transaction, SunOpta has suspended its quarterly earnings calls and will no longer provide quarterly or annual guidance, which may affect investor expectations regarding the company's future performance.
- CEO's Strategic Vision: CEO Brian Kocher emphasized that the partnership with Refresco will provide the necessary resources and scale to unlock SunOpta's full potential in the rapidly growing better-for-you food and beverage market, further solidifying its market position.
See More
SunOpta Cleared for Acquisition by Refresco
- Acquisition Approval: SunOpta Inc. (STKL) has received early termination approval under the Hart-Scott-Rodino Antitrust Improvements Act, facilitating the acquisition process and marking a key condition met for the deal.
- Transaction Details: Refresco is acquiring SunOpta for $6.50 per share in an all-cash transaction valued at $1.1 billion, expected to close this quarter, indicating Refresco's strong intent to acquire.
- Regulatory Requirements: Despite the early approval, the acquisition still requires remaining regulatory clearances, approval from SunOpta shareholders, and consent from the Ontario Superior Court, ensuring compliance and legality of the transaction.
- Market Impact: This acquisition is poised to not only expand Refresco's market share but also potentially provide SunOpta with new growth opportunities, further driving its expansion in the consumer goods sector.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating Peakstone Realty Trust (NYSE:PKST) for its sale to Brookfield Asset Management at $21.00 per share in cash, which may infringe on shareholder rights.
- Shareholder Rights Protection: Coterra Energy Inc. (NYSE:CTRA) is being sold to Devon Energy Corporation for 0.70 shares of Devon stock per Coterra share, prompting Halper Sadeh LLC to encourage shareholders to understand their legal rights and options.
- Transaction Terms Review: The deal between Udemy, Inc. (NASDAQ:UDMY) and Coursera, Inc. involves exchanging 0.800 shares of Coursera stock for each Udemy share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
- Legal Service Commitment: Halper Sadeh LLC offers legal services on a contingency fee basis, aiming to secure greater rights for affected shareholders and ensure their legal interests are protected in these transactions.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating companies such as Calavo Growers, Inc., European Wax Center, Inc., and SunOpta Inc. for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights.
- Transaction Details: Calavo Growers is being sold for $14.85 in cash and 0.9790 shares of Mission Produce per share, while European Wax Center's sale price is $5.80 per share in cash, and SunOpta's is $6.50 per share in cash, potentially limiting superior competing offers.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options, promising to handle matters on a contingent fee basis, aiming to secure increased consideration and additional disclosures for affected shareholders.
- Legal Service Commitment: The firm represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors in the past, demonstrating its expertise in protecting investor rights.
See More
Investigation Alerts for Multiple Company Mergers
- Rallybio Merger Investigation: Rallybio is set to be acquired by Candid Therapeutics, with pre-transaction shareholders expected to own approximately 3.65% of the combined entity, raising concerns about whether the board breached fiduciary duties by failing to ensure a fair process, potentially impacting shareholder rights.
- SunOpta Acquisition Details: SunOpta will be acquired by Refresco for $6.50 per share in cash, with investigations focusing on whether the board violated fiduciary duties by not securing fair value for shareholders in the transaction.
- Talkspace Transaction Review: Talkspace is being acquired by Universal Health Services for $5.25 per share in an all-cash deal worth $835 million, with investigations questioning whether the board failed to conduct a fair process, which could harm shareholder interests.
- Kennedy-Wilson Merger Investigation: Kennedy-Wilson will be acquired by a consortium, including its chairman, for $10.90 per share in cash, with investigations looking into whether the board breached fiduciary duties by not ensuring a fair transaction process, potentially affecting shareholder value.
See More
